Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Balkan Journal of Medical Genetics
Volume 14 (2011): Issue 2 (December 2011)
Open Access
Amplification of
c-MYC
and
MLL
Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11
S Angelova
S Angelova
,
M Jordanova
M Jordanova
,
B Spassov
B Spassov
,
V Shivarov
V Shivarov
,
M Simeonova
M Simeonova
,
I Christov
I Christov
,
P Angelova
P Angelova
,
K Alexandrova
K Alexandrova
,
A Stoimenov
A Stoimenov
,
V Nikolova
V Nikolova
,
I Dimova
I Dimova
,
P Ganeva
P Ganeva
,
N Tzvetkov
N Tzvetkov
,
E Hadjiev
E Hadjiev
and
S Toshkov
S Toshkov
| Dec 08, 2011
Balkan Journal of Medical Genetics
Volume 14 (2011): Issue 2 (December 2011)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 08, 2011
Page range:
17 - 24
DOI:
https://doi.org/10.2478/v10034-011-0043-y
Keywords
Gene amplification ()
,
genes
,
Acute myeloid leukemia (AML)
,
Myelodysplastic syndromes (MDS)
,
Myeloid malignancies
,
Trisomy chromosomes of 8 or 11
This content is open access.
S Angelova
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
M Jordanova
Children Hospital of Hematological Diseases, Sofia, Bulgaria
B Spassov
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
V Shivarov
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
M Simeonova
Department of Medical Genetics, Medical University Hospital, Pleven, Bulgaria
I Christov
Department of Hematology, Medical University Hospital, Pleven, Bulgaria
P Angelova
Department of Medical Genetics, Medical University Hospital, Pleven, Bulgaria
K Alexandrova
Department of Hematology, Medical University Hospital, Sofia, Bulgaria
A Stoimenov
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
V Nikolova
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
I Dimova
Department of Medical Genetics, Medical University, Sofia, Bulgaria
P Ganeva
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria
N Tzvetkov
Department of Hematology, Medical University Hospital, Pleven, Bulgaria
E Hadjiev
Department of Hematology, Medical University Hospital, Sofia, Bulgaria
S Toshkov
Laboratory of Cytogenetics and Molecular Biology, National Specialized Hospital for Active Therapy of Hematological Diseases, Sofia, Bulgaria